In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

Princess of Wales Kate Middleton made a personal visit to thank the medical staff and speak with patients at the Royal ...

The ITC found that "multiple bad actors" have been importing or selling knockoff copies of Lilly's tirzepatide.

Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro ... Jr. is a trending news reporter for USA TODAY. Reach him at fernando.cervantes@ ...

Eli Lilly (LLY) announced today that its blockbuster ... president of Lilly Cardiometabolic Health and Lilly USA, in a press release. The approval is based on a clinical trial from earlier this ...

Eli Lilly announced FDA approval of Zepbound ... and president of Lilly Cardiometabolic Health and Lilly USA. “Zepbound is the first medication that significantly improves moderate-to-severe ...

Eli Lilly's Zepbound has been approved by the ... loss in adults with obesity," said Patrik Jonsson, president of Lilly USA. The trials found that adults on Zepbound alone lost an average of ...

Eli Lilly’s blockbuster obesity drug ... and president of Lilly Cardiometabolic Health and Lilly USA said: “Today, many cases of OSA go undiagnosed and untreated, leaving millions at risk ...